Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...
Researchers from The University of Osaka have developed a novel reverse genetics system to study norovirus, the leading cause ...
On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
Everon Healthcare is a distinguished Chinese company focused on the research, development and industrialization of recombinant triple-helical collagen.
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft ...
Zoetis’ Vanguard Recombishield is a nonadjuvanted, recombinant injectable therapy. Vanguard Recombishield was licensed by the US Department of Agriculture (USDA) on March 4, 2025. It uses recombinant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback